T1	p 216 259	44 patients with inclusion body myositis in
T2	i 90 115	methotrexate or placebo .
T3	i 159 176	oral methotrexate
T4	i 286 304	placebo-controlled
T5	i 525 537	methotrexate
T6	i 553 560	placebo
T7	i 840 852	methotrexate
T8	i 883 895	methotrexate
T9	o 327 389	Mean change of quantitative muscle strength testing sum scores
T10	o 430 477	Quantitative muscle strength testing sum scores
T11	o 660 716	manual muscle testing sum scores , activity scale scores
T12	o 778 808	Serum creatine kinase activity
T13	o 929 944	muscle weakness
T14	o 959 991	serum creatine kinase activity .